Difference between revisions of "Work Product for Review"

From QIBA Wiki
Jump to navigation Jump to search
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
−
==Public Comment on QIBA Profiles and Protocols==
+
QIBA '''[[Profiles|Profile documents]]''' are posted for '''[[Public Comment Process|Public Comment]]''' to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.   
−
QIBA documents are posted for Public Comment to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details. 
 
−
 
 
−
The [[Committees|QIBA Biomarker Committees]] consider all comments submitted, and where appropriate, post responses.   
 
  
 
==Comment Submission==
 
==Comment Submission==
  
−
* Visit the [https://fs22.formsite.com/QIBA/QIBA_Public_Comment_Form/index.html QIBA Public Comment Webform].
+
* Visit the [https://forms.gle/qxPUJx7qbKSBaE9V6 QIBA Public Comment Form].
 
:* Select the document you are commenting on from the dropdown menu
 
:* Select the document you are commenting on from the dropdown menu
−
:* Provide your name or initials
+
:* Provide your name and email address
−
:* Follow the other instructions on the page
+
:* Add the Profile section and line number (if applicable) to which your comment refers
−
* e-mail ([mailto:sweinmann@rsna.org Susan Weinmann]) with ''general comments'' about the Profile/Protocol concept, structure, process, etc.
+
:* Describe the issue and your propose a resolution
−
 
+
:* When you have entered each of your comments, you may submit the form
−
 
+
* e-mail ([mailto:qiba@rsna.org QIBA Team]) with ''general comments'' about the Profile/Protocol concept, structure, process, etc.
−
==QIBA Profiles and Protocols for Reference==
 
−
 
 
−
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | QIBA Profile: <big><font color=red> QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016</font></big>]] ''The Public Comment period ends February 1, 2017.''
 
−
 
 
−
*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|QIBA SPECT Profile Conformance Checklist]]
 
−
 
 
  
−
*[[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx|QIBA Profile: <big><font color=red> QIBA Profile: Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening, June 1, 2016</font></big>]] ''The Public Comment period has closed''
+
The [[Committees|QIBA Biomarker Committees]] consider all comments submitted, and where appropriate, post responses.
  
−
*[[Media:QIBA Small Nodule Profile References - Accuracy.xlsx|QIBA Spreadsheet: <big><font color=red> Small Nodule Profile References_Accuracy. Version for Public Comment. June 1, 2016 </font></big>]] ''The Public Comment period has closed''
+
==Public Comment Documents==
  
−
*[[Media:QIBA Small Nodule Profile References - Precision.xlsx|QIBA Spreadsheet: <big><font color=red> Small Nodule Profile References_Precision. Version for Public Comment. June 1, 2016 </font></big>]] ''The Public Comment period has closed''
+
see http://qibawiki.rsna.org/index.php/Profiles
  
  
 
*[[Document Archive]]
 
*[[Document Archive]]

Revision as of 21:33, 22 June 2021

QIBA Profile documents are posted for Public Comment to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.

Comment Submission

  • Select the document you are commenting on from the dropdown menu
  • Provide your name and email address
  • Add the Profile section and line number (if applicable) to which your comment refers
  • Describe the issue and your propose a resolution
  • When you have entered each of your comments, you may submit the form
  • e-mail (QIBA Team) with general comments about the Profile/Protocol concept, structure, process, etc.

The QIBA Biomarker Committees consider all comments submitted, and where appropriate, post responses.

Public Comment Documents

see http://qibawiki.rsna.org/index.php/Profiles


Retrieved from "https://qibawiki.rsna.org/index.php?title=Work_Product_for_Review&oldid=16936"